
Inside Precision Medicine: Immunotherapy boosts head & neck cancer treatment
Inside Precision Medicine recently featured a clinical trial led by the University of Cincinnati's Trisha Wise-Draper, MD.
Wise-Draper, associate professor of medicine in the Division of Hematology/Oncology in UC’s College of Medicine, Head and Neck Center of Excellence co-leader, medical director of the University of Cincinnati Cancer Center Clinical Trials Office and Lab and a UC Health physician, recently published research showing that adding immunotherapy drug pembrolizumab to the standard of care for head and neck cancer patients increased survival rates for intermediate risk patients.
Wise-Draper told Inside Precision Medicine the "high pathological response rate just after 1 dose of treatment and the survival benefit associated" was a surprising result of the study. In more than 50% of the patients, the drug caused the tumor to die before surgical resection—a much higher response than had been shown in previous studies of recurrent or metastatic head and neck cancer. Within this group, 100% of the patients were disease-free at one year.
“It was a really strong predictor of patients who are going to do well on this treatment,” Wise-Draper said. “Hopefully that is going to help us design trials to better understand who is going to respond and who is not.”
Read the Inside Precision Medicine story.
Wise-Draper's research was also featured in a Pharmacy Times article. Read the Pharmacy Times article.
Featured photo at top courtesy of UC Health.
Related Stories
CityBeat: When can police arrest demonstrators?
February 12, 2025
Ryan Thoreson, an assistant professor at the University of Cincinnati College of Law, spoke with CityBeat publication about legal precedence and hateful speech for a story about a recent neo-Nazi demonstration in Greater Cincinnati.
Student brilliance in action: Attend the Three-Minute Thesis...
Event: February 26, 2025 4:30 PM
The Graduate College invites the UC community to attend the Three Minute Thesis Competition to witness graduate students present their research in a compelling three-minute format using just one PowerPoint slide. This event provides a unique opportunity to engage with innovative research and storytelling.
UC professor seeks to make death care more inclusive
February 12, 2025
Jennifer Wright-Berryman of UC’s College of Allied Health Sciences is one of the founders of Equal Deathcare, a web-based resource where LGBTQIA+ individuals can find inclusive and affirming end-of-life and death care.